cyclohexanone has been researched along with Leukemia L5178 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kakeya, H; Kataoka, T; Mitsui, T; Miyake, Y; Osada, H | 1 |
1 other study(ies) available for cyclohexanone and Leukemia L5178
Article | Year |
---|---|
ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
Topics: Animals; Apoptosis; Cell Line, Tumor; Clone Cells; Cyclohexanones; Cytoplasmic Granules; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; DNA Fragmentation; Epitopes, T-Lymphocyte; Epoxy Compounds; Exocytosis; Fas Ligand Protein; Immunosuppressive Agents; Isoantigens; Leukemia L5178; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Perforin; Pore Forming Cytotoxic Proteins; Solubility; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 2004 |